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Abstract
Introduction: Hypertension is a cause and consequence of  chronic kidney disease globally. The other factors that work in con-
cert with hypertension to cause CKD are yet to be clearly elucidated.  Studies have identified proteinuria, dyslipidemia, obesity, 
smoking and family history of  CKD  as renal risk factors. Due to the high morbidity and mortality associated with occurrence 
of  CKD including the enormous financial burden involved in its management, the knowledge of  prevention and understand-
ing of  the risk factors for development of  CKD is highly essential. Therefore, Identifying well defined risk factors that display 
strong graded association with the occurrence and progression of  CKD can help in elucidating potential targets for disease 
modification. 
Objective: The aim of  this study was to determine the prevalence of  renal risk factors and their impact on kidney function in 
newly diagnosed hypertensive Nigerians.
Methods: This was a case control study of  two hundred and fifty newly diagnosed hypertensive Nigerians recruited from two 
contiguous hospitals in an urban setting in south western Nigeria. Another group of  two hundred and fifty apparently healthy 
age and sex matched normotensive Nigerians in the same community were recruited as controls.
Results: Seventy (28%) of  the newly diagnosed hypertensives had estimated glomerular filtration rate of  less than 60ml/min, 
while 42.4% and 18.8% of  the subjects and the controls had microalbuminuria respectively. The newly diagnosed hypertensives 
had significantly higher prevalence of  analgesic use (86.4% versus 41.6%, p < 0.001), alcohol consumption (20.8% versus 12%, 
p = 0.008), use of  canned salted food (18.8% versus 8.4%, p= 0.001) and central obesity (36.1% versus 26.8%, p= 0.025) com-
pared to controls.
Conclusion: There is a significant occurrence of  modifiable renal risk factors in newly diagnosed hypertensives and this offers 
a platform for instituting preventive strategies in the community.
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Introduction
Hypertension is an important and a major global pub-
lic health challenge with high prevalence. It affects more 
people in developing countries and it is projected that by 
2025, almost three- quarters of  people with hypertension 
will be living in developing countries1.  It is a major cause 
of  chronic kidney disease (CKD) globally and it is asso-
ciated with increased risk of  cardiovascular diseases2. It is 
also the most prevalent cause of  end stage renal disease in 
sub Saharan Africa with figures ranging from 25-50%3,4. 
The degree of  functional impairment in those who even-
tually develop CKD is highly variable and this has been 
attributed to individual variability of  risk. The need to 
also predict those who may eventually develop CKD has 
further led to the search for risk factors which in concert 
with hypertension significantly impact on renal function 
and ultimately leading to ESRD.
Factors implicated as being responsible for CKD pro-
gression in hypertensives have been classified into initiat-
ing factors such as age, race (African Americans), gender, 
dyslipidaemias and obesity while the perpetuating factors 
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which drive the process include; smoking, anaemia, oli-
gonephroma, level of  proteinuria, and the systolic blood 
pressure level5.
In a follow up study of  500 patients with essential hy-
pertension, Pereira reported that proteinuria was found 
in 42%, while 18% developed chronic renal insufficien-
cy over a period of  time6. Cigarette smoking, analgesic 
consumption in significant quantity amongst others were 
seen in patients with hypertension induced chronic renal 
failure in Nigeria in an earlier report by Akinsola et al7.
The multiple risk factor interventional trial (MRFIT) 
study had also reported that the absolute risk of  end 
stage renal disease was highest for those with a baseline 
blood pressure in the highest category of  systolic blood 
pressure and diastolic blood pressure respectively. The re-
lationship of  blood pressure and renal damage was also 
positive and continuous through blood pressure range8. 
Strategies for prevention of  hypertension induced CKD 
must have a holistic approach based on the identification 
of  renal risk factors that can in concert with hypertension 
promote the development of  CKD, and its sustainability.
Risk profiling is a quantitative analysis of  factors accen-
tuating disease progression and its characteristics, the 
early identification of  high risks should therefore form 
the basis for instituting preventive interventions. This be-
comes imperative in view of  the rising global incidence 
and prevalence of  hypertension induced kidney damage 
in developing countries. This study was thus carried out 
to determine the occurrence and pattern of  renal risk 
factors among adult Nigerians with newly diagnosed hy-
pertension and also aimed at detecting the relationship 
between the risk factors and kidney function.
Methods
This prospective study was performed at the Ladoke 
Akintola University Teaching Hospital(LAUTECH), 
Osogbo, Nigeria and at the General hospital, Osogbo 
over an 18 month period from Jan 1st 2009 till August 
30th, 2010. Ethical approval was obtained for this study 
from the ethical board of  LAUTECH  with protocol 
number LTH/EC/2009/12/56.
 Adults aged ≥ 35 years with newly diagnosed hyperten-
sion from General Outpatient units of  both centres were 
enrolled for the study.
Study population
This consisted of  250 consecutive adults who fulfilled the 
inclusion criteria for this study and  who were newly di-
agnosed to have hypertension and another 250   age- and 
sex-matched healthy controls within the same community 
were also recruited for the study. The participants were ≥ 
35 years of  age, yet to commence antihypertensive drugs, 
and gave informed consent to be included in the study.
 Primary hypertension was defined as systolic blood pres-
sure ≥ 140mmHg and/ or diastolic pressure  ≥ 90mmHg, 
with the absence of  red cells and granular casts from the 
urine and a protein/creatinine ratio ≤ 2.0 at baseline.
Patients with biochemical and clinical evidence suggestive 
of  glomerulonephritis were also excluded.
A structured questionnaire was administered seeking in-
formation on socio-demographics such as age, sex, mar-
ital status and social class as established by income and 
occupation.  History of  established renal risk factors 
such as smoking, alcohol intake, use of  salt, use of  herbal 
medicines or remedies, analgesic use, protein intake, fam-
ily history of  hypertension, diabetes, or salient symptom-
atology of  chronic kidney disease which included noctu-
ria, passage of  frothy urine and facial swelling amongst 
others were also obtained.  
Alcohol intake was assessed with separate questions about 
the type, amount of  alcohol consumed per week and the 
duration of  alcohol intake prior to study enrolment. 
Study participants also answered questions on smoking 
habits, current smoking status and the average number of  
cigarettes they smoked per day.The  duration of  use of  
herbal medications were also accessed.  Questions were 
also asked concerning use of  salts including adding salt to 
food at table and frequency of  consumption of  canned 
salted foods.  
A waist circumference of  ≥ 102 cm for male and ≥ 88 
cm for female were taken as indicative of  central/truncal 
obesity.Urinalysis was done using dipstick (Combi 9®) 
for the presence of  protein, red blood cells, white blood 
cells, nitrite in urine samples.
Albumin: creatinine (ACR) ratio was done using clinitekR 
50 (Bayer Diagnostics urine chemistry analyser, Bayer 
corporation, Elkhart, USA) for urine samples that were 
negative for proteinuria (macroproteinuria) with Combi 
9 dipsticks. 
Microalbuminuria was defined as an ACR of  30 mg/g to 
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299mg/g while macroalbuminuria was defined as an ACR 
of  ≥ 300mg/g.
Sample for lipid profile, blood glucose and haemoglo-
bin concentration were determined automatically using 
an auto analyzer machine (SysmexInc, IL 60060, USA). 
Serum creatinine was measured by a modified kinetic 
Jaffe reaction. (Alkaline picric acid method, kits from 
RANDOX Laboratory Ltd. US), and serum electrolytes 
(sodium, potassium and uric acid) were analysed using 
flame-photometer.
Diabetes was defined as fasting blood glucose ≥ 
7.0mmol/l (126mg/dl).
The abbreviated Four Variable Modification of  Diet in 
Renal Disease (MDRD) study formulawas used to esti-
mate the glomerular filtration rate; 
eGFR (ml/1.73m2) = 186 x PCr (mg/dl)-1.154 x Age(yrs) 
-0.203 x 0.742 (if  female) x 1.210 (if  black).
Where eGFR is the estimated glomerular filtration rate, 
PCr is the plasma creatinine.  
The tests (Haemogram, renal function tests, uric acid, 
fasting blood sugar and lipid profile) were carried out on 
all subjects and controls.
Statistical analysis
Analysis was done using Statistical Package for Social Sci-
ences (SPSS) version 15.
Summary statistics such as means, medians and standard 
deviation were used to summarize quantitative variables 
while qualitative data were summarized using frequencies 
and proportions. 
The frequency of  each risk factor was compared between 
the hypertensive patients and controls.  The correlation 
between quantitative variables was tested using the Pear-
son correlation analysis while chi square test was used 
for two qualitative variables. The t-test and Analysis of  
Variance were used to compare means of  two and three 
categories respectively. Bar charts were used to represent 
qualitative variables.
The risk profile of  each patient with newly diagnosed 
hypertension was determined by combining nine select-
ed risk factors for CKD namely smoking, alcohol intake, 
herbal concoction use, excessive salt intake, obesity, anal-
gesic use, fasting hyperglycaemia, proteinuria  and family 
history of  chronic kidney disease. The number of  risk 
factors was then grouped into 3 categories- 0 - 3 risks, 
>3-6 risks, > 6 risks representing mild, moderate and se-
vere degrees respectively.  The magnitude of  the risk fac-
tors mild, moderate, or severe (depending on presence of  
0-3, >3-6, > 6 risks) was compared between subjects and 
controls using chi-square test or student t-test for quanti-
tative and qualitative variables respectively.
The independent predictors of  outcomes such as GFR 
were identified using multiple linear regression analysis 
while the multiple logistic regression was used for di-
chotomous outcomes such as CKD.  For a variable to be 
entered into the multiple logistic regression model, the 
p-value on the chi-square tests must have been less than 
0.1 (10%).  Hence the logistic regression analysis was car-
ried out for predictors which were significantly associated 
with the outcome at p < 0.1 on chi square test.  Odd 
ratios and their 95% confidence intervals were reported. 
The level of  significance for all tests was 5% (p < 0.05).
Results
There were 250 study participants with newly diag-
nosed hypertension and 250 age and sex matched ap-
parently healthy normotensive controls. The mean age 
was 55.7±11.3 years for the hypertensive patients and 
55.2±12.5 years for the controls.There were 121 male 
subjects and 115 male controls respectively.
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Table 1:  Comparison of anthropometric indices between hypertensive patients and controls 
  
Anthropometric 
measurement 
Hypertensives 
Mean± SD 
Controls 
Mean± SD 
P value 
  
Weight (kg) 
  
67.8±15.0 
  
65.8±13.3 
  
0.124 
Height (m) 1.59±0.09 1.58±0.07 0.466 
Body Surface Area (m2) 1.69±0.19 1.67±0.15 0.142 
BMI (Kg/m2) 27.0±6.3 26.4±5.6 0.272 
BMI Class       
      Underweight 4(1.6) 6(2.4) 0.298 
      Normal 99(39.9) 105(42.2)   
      Overweight 79(31.9) 89(35.7)   
      Obesity 66(26.6) 49(19.7)   
Waist Circumference       
      Normal 159(63.9) 183(73.2) 0.025 
      Abnormal 90(36.1) 67(26.8)   
                      BMI – Body Mass Index 
Table 1 shows the means and standard deviation of  se-
lected anthropometric indices among the hypertensive 
patients and controls. There was no statistically signifi-
cant difference in the mean values of  weight (p = 0.124), 
height (p = 0.466), body mass index (p = 0.272), waist cir-
cumference (p = 0.163) and body surface area (p = 0.142) 
of  the hypertensive patients and the controls. When the 
anthropometric indices were categorized there were sig-
nificant differences in the waist circumference.  A higher 
proportion of  the hypertensive patients had abnormal 
waist circumference compared to controls (p = 0.025). 
Body mass index remained non- significant when catego-
rized (p = 0.298).
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Table 2:  Prevalence of risk factors for CKD amongst hypertensive patients and controls 
  
  
Risk Factors 
  
    Hypertensives 
      % 
  
Controls 
 % 
  
  
P-value 
  
Analgesic Use 
  
86.4 
  
41.6 
  
<0.001* 
Smoking 2.8 4.4 0.333 
Alcohol Use 20.8 12.0 0.008* 
Herbal Use 51.6 26.1 <0.001* 
Use of salted food 18.8 8.4 <0.001* 
Family history of 
DM 
  
7.2 8.0 0.736 
Family history of 
hypertension 
35.2 10.2 <0.001* 
  
Obesity (BMI ≥ 
30kg/m2) 
  
26.6 19.7 0.289 
Central obesity 36.1 26.8 0.025* 
Fasting 
Hyperglycaemia 
  
3.3 1.2 0.021* 
Macroalbuminuria 5.6 0.7 <0.001* 
Microalbuminuria 42.0 18.8 0.001* 
                      
                     Key: BMI – Body mass index * = Statistically significant 
Table 2 shows that newly diagnosed hypertensives had 
significantly higher prevalence of  analgesic use (86.4% vs. 
41.6%, p<0.001), alcohol use (20.8% vs. 12%, p = 0.008), 
herbal use (51.6% vs. 26.1%, p<0.001), use of  canned 
salted food (18.8% vs. 8.4%,  p = 0.001), and central obe-
sity (36.1% vs. 26.8%, p = 0.025).
The mean serum creatinine among the hypertensive pa-
tientswas 91.31±15.37µmol/L (range 65-129µmol/L) 
and the mean serum creatinine among the controls was 
91.2±15.9 µmol/L (range 64-128µmol/L).  There was 
however no significant statistical difference in the mean 
serum creatinine values between the two groups (t =0.051, 
p =0.959). Table 3 also shows the indicators of  renal func-
tion compared between newly diagnosed hypertensives 
and controls. Macroalbuminuria and microalbuminuria 
were significantly commoner among subjects compared 
to controls (p<0.001).  Eighty one (42%) hypertensive 
patientscompared to 26 (18.8%) of  controls had micro-
albuminuria, while 14(5.6%)of  the hypertensive patients 
compared with 1 (0.7%) control had macroalbuminuria.
 Seventy (28%) of  the hypertensive patients and ten (4%) 
of  the controls had estimated GFR less than 60mls/
min/1.73m2  respectively.
Table 3:  Comparison of indicators of reduced renal function between  
hypertensive patients and controls. 
  
Indicator Hypertensives 
n (%) 
Controls 
n (%) 
P value 
  
Serum creatinine >120(µml/l) 
Microalbuminuria (mg/g) 
Macroalbuminuria (g/l) 
  
9(6.0) 
81(42.0) 
14(5.6) 
  
3(2.0) 
26(18.8) 
1(0.7) 
  
0.079 
<0.001 
<0.001 
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Figure 1 
Figure 1 shows the distribution of  study population ac-
cording to albumin- creatinine ratio (ACR).  The preva-
lence of  microalbuminuria in the hypertensive patients 
was 42.4% compared to 18.8% in the controls.  This was 
statistically significant p < (0.001). Macroalbuminuria was 
also commoner among the hypertensive patients when 
compared to the controls (5.6% vs. 0.7%, p = 0.001)
The output from the logistic regression of  impaired 
kidney function (GFR < 60ml/min/m2) on variables is 
shown in Table 4.  After adjusting for the various risk fac-
tors identified in this study, the major predictors of  im-
paired kidney function were gender – with females more 
likely to develop the disease compared to male partici-
pants (OR =0.244, 95% CI = 0.108 – 0.551); age which 
indicates that the hypertensive patientswere more likely to 
develop CKD (OR = 1.064, 95% CI = 1.043-1.085),and 
fasting hyperglycaemia (OR = 4.799, 95% CI = 1.602 – 
14.374) .
Table 4: Regression coefficients and confidence intervals from regression  
of estimated GFR on selected risk factors for CKD among subjects 
   
Variable Regression 
coefficient 
95%  Confidence 
interval 
     P value 
Age -1.00 -1.11  to -0.89 <0.001* 
Gender (male vs female) 11.74 9.16 to 14.32 <0.001* 
Waist circumference 0.16 0.02 to  0.30 0.030* 
MABP 0.22 -0.002 to 0.44 0.052 
Smoking -1.56 -12.84  to 9.72 0.786 
BMI 1.12 0.81 to 1.44 <0.001* 
Systolic blood pressure -0.16 -0.34 to 0.018 0.078 
Herbal concoction use -0.893 -4.370  to 2.585 0.614 
*Significant at 5% level 
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The comparison of  mean eGFR among the risk factor 
categories is shown in Table 5. The risk factor categories 
were grouped into 3: less than 3 risks, 3-6 risks and great-
er than 6 risks.  The eGFR decreased with the number of  
risk factors and the difference was statistically significant 
(p <0001). Also, the newly diagnosed hypertensives with 
risk factors have significantly lower mean eGFR when 
compared with newly diagnosed hypertensive without 
risk (59.80 ± 17.55 vs 74.68 ±  20.92mls/min, p = (0.001). 
Figure 2 shows a significant negative correlation between 
eGFR and magnitude of  risk factors (r = -0.597, p < 
0.001).
    Table 5: Mean eGFR amongst the risk groups (hypertensive subjects) 
 
Risk Group Mean eGFR ± 
SD 
F P-value 
<3risks      (n = 97) 
3-6 risks    (n = 101) 
> 6 risks     (n=52) 
84.6 (14.9) 
77.2 (19.9) 
68.9 (16.8) 
12.182 <0.001 
 
 
 
 
Figure 2 showing the multiple regression analysis of the  
risk factors on renal function 
Nine risk factors namely smoking, alcohol intake, herbal 
concoction use, excessive salt intake, proteinuria, obesity, 
fasting hyperglycaemia, analgesic use and family history 
of  CKD were selected in the categorization of  the level 
of  CKD risk.  These risk factors were used in classifying 
patients based on the number of  risk factors they possess. 
A higher number of  controls had less than 3 risk fac-
tors compared to the hypertensive patients.   About 165 
(66.0%) of  the hypertensive patients had greater than 6 
risk factors while 42(16.8%) had between 3-6 risk factors. 
These were higher when compared to controls. (Table 6)
Table 6: Risk profiling amongst hypertensive patients and controls 
 
RISK GROUP Frequency in hypertensives 
n (%) 
       Frequency in controls 
n (%) 
< 3risk factors 
3–6 risk factors 
>than 6 risk factors 
Total 
43(17.2) 
42 (16.8) 
165 (66.0) 
250(100) 
177 (70.8) 
30 (12.0) 
43 (17.2) 
250 (100) 
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Discussion
In this study, renal function was assessed by estimated 
glomerular filtration rate (GFR) using the Modification 
of  Diet in Renal Disease (MDRD) formula and kidney 
damage assessed by albuminuria9. Seventy (28%) of  the 
newly diagnosed hypertensives had estimated GFR < 
60ml/min and 42.4% had microalbuminuria, compared 
with 18.8%  with microalbuminuria amongst the controls. 
The prevalence of  the microalbuminuria in the hyperten-
sive patients in this study is similar to the 45.5% prev-
alence reported by Nwankwo et al in newly diagnosed 
hypertensives10. This figure was also higher than figures 
found by Olatunde et al who reported microalbuminuria 
of  17.4% in a similar study done at Ile- Ife, Nigeria11.
The prevalence observed in the control population in this 
study is higher than that found by Coresh et al and the 
Dutch PREVEND study ( 9.3% and 7.2%) respective-
ly12,13.
The relatively significant presence of  microalbuminuria 
in this study amongst newly diagnosed hypertensives may 
indicate early endothelial damage and this portends future 
glomerular damage and CKD. Specifically, the severity of  
blood pressure and increased systemic permeability to al-
bumin possibly due to endothelial dysfunction had been 
found to play an important role in its development.  Ad-
ditional factors such as lipid abnormalities, prothombotic 
factors, increased activities of  RAS and systemic inflam-
mation have also been implicated13,14.The goal of  drug 
treatment of  hypertension should include amelioration/
reduction of  associated microalbuminuria from the onset 
, particularly among population pre disposed to chronic 
renal disease.
The prevalence of  CKD in this study(as defined by GFR 
< 60ml/min/1.73m2) is 28% in the newly diagnosed hy-
pertensives is similar to what was found in a  study by 
Ayodele et alwho reported a prevalence of  23.1% among 
newly diagnosed hypertensive patients15.  The prevalence 
was however higher than 4.7%, 5.7% and 8% reported 
in NHANES16, EPIRCE17 and Democratic Republic of  
Congo18. The high prevalence found may not be uncon-
nected to the background hypertension in our subjects 
which confers higher risk of  kidney damage in this pop-
ulation when compared to the other studies which largely 
consisted of  untargeted population.
 
The mean serum creatinine among the newly diagnosed 
hypertensives was higher among subjects compared to 
controls.  The prevalence of  impaired kidney function 
using a cut off  value of  serum creatinine > 120µmol/L 
was 6.0% among the newly diagnosed hypertensives. The 
Kidneys have strong compensatory function and it may 
take about 50% loss of  its function before serum creati-
nine starts to rise.  Therefore, measurement of  serum cre-
atinine alone may under-diagnose CKD.  It is advocated 
by NKF that renal function be assessed using estimated 
GFR and other markers of  kidney damage which provide 
a more sensitive representation of  kidney function or al-
lows for early diagnosis of  CKD for prompt institution 
of  management19.
The study found significant association between increas-
ing age and impaired kidney function in both populations 
studied.  As reported in other studies, which shows in-
creasing prevalence of  low GFR with age, elderly partic-
ipants have highest prevalence of  CKD and the relation-
ship remains significant even after regression analysis20,21. 
This is in agreement with findings from other studies. 
Rowe et al and Linderman had reported a natural de-
cline of  kidney function with age22,23.  Possible reasons 
adduced by the latter for this association are reduction 
in the number of  nephron, renal mass and presence of  
nephrosclerosis in ageing. The mean age of  the partici-
pants, increased prevalence of  risk factors and ethnicity 
(black race) are likely to have contributed to the higher 
prevalence in this study than some of  the other studies. 
As impaired kidney function is commoner in the older 
age group, the recommendation to screen people in this 
age group would be an important strategy for detection 
of  chronic kidney disease.  
It was observed that values suggestive of  reduced renal re-
serve (eGFR <60mls/min) was commoner in the female 
(32.9%) than male (20.8%).  Female gender independently 
predicts CKD in this study.  AusDiab20, NHANES16 and 
China21 studies showed significant higher female gender 
prevalence of  CKD.  Data regarding the role of  gender 
in determining renal risk in humans are somewhat contra-
dictory.  In general, the prevalence of  CKD was greater 
in male than female regardless of  age and also in various 
ethnic groups.  In this study, the female subjects were old-
er, had higher SBP and DBP (although these values were 
not statistically significant) and these findings may explain 
the higher prevalence of  eGFR < 60mls/min and albu-
minuria in females compared to males.  However, many 
studies have shown higher prevalence of  ESRD in males 
than females22,23,24.
African Health Sciences Vol 19 Issue 4, December, 2019 2870
Obesity represents a state of  excess storage of  body fat 
and could be defined as an excess body weight for height. 
With prolonged obesity, there is resultant further impair-
ment of  renal-pressure natriuresis, leading to a more se-
vere hypertension and a gradual loss of  kidney function25. 
Aryee et al in a case control study involving 241 partic-
ipants noted that hypertensives with chronic kidney dis-
ease had higher anthropometric indices, it was observed 
that body adiposity index and abdominal volume index 
were associated with corresponding incremental changes 
in the bloodpressure26.  In this study, a significant num-
ber of  study participants (newly diagnosed hypertensives) 
had central obesity.
Smoking as a risk factor to renal damage was also not-
ed in this study, as it may contribute to renal damage via 
sympathetic nervous activation, sustained hypertension 
via promotion of  renal atherosclerosis and effects on 
endothelial functions27. Generally it shortens the interval 
from microalbuminuria to overt nephropathy and accel-
erates progression of  nephropathy and loss of  glomeru-
lar filtration rates27.
The habitual consumption of  alcohol was seen in 20.8% 
of  the subjects. It causes an increase in sympathetic ac-
tivity, stimulation of  the renin angiotensin-aldosterone 
system and an increase of  intracellular calcium levels with 
a subsequent increase in vascular reactivity29. However 
these seems to be speculative.
Excessive salt consumption was seen in 18.8% of  the 
subjects compared with 8.4% among the controls (P< 
0.05). In patients with hypertension, an increase in salt 
intake often increases the GFR, vascular resistance, calcu-
lated intraglomerular capillary pressure and protein excre-
tion30. Studies such as DASH and INTERSALT have all 
suggested a reduction in salt quantities to reduce cardio-
vascular morbidity. The KDIGO recommends a sodium 
intake of  less than 90mmol/day(2g) which corresponds 
to 5g of  sodium chloride9.
Analgesic consumption was also significant among 86.4% 
of  the subjects compared with the controls. In Nigeria 
the pattern of  analgesic consumption and its contribu-
tion to renal disease is not fully known. Abioye-kuteyi 
found a prevalence of  74.7% in a rural area consisting 
of  unskilled workers31. Hypertension, pre-existing renal 
disease are known risk factors for renal failure after inges-
tion of  NSAIDS32.  
Chronic analgesic nephropathy is a slowly progressive 
renal disease resulting from daily use for many years of  
mixture containing at least two analgesics (e.g aspirin, 
paracetamol, phenacetin) and caffeine, codeine, and/or 
barbiturates, which may lead to psychological dependence 
and overuse. The cumulative dose of  analgesics required 
to cause renal impairment is about 4kg over 2 years31. 
When the risk factors were grouped into three: less than 
3(mild risk), 3-6 risk (moderate risks), ≥ 6 risk (high risks), 
there was significant difference in the prevalence of  renal 
risk in the newly diagnosed hypertensives when com-
pared to the controls.  Occurrence of  multiple risks was 
associated with reduction in renal function, there was an 
inverse relationship between occurrence of  multiple risks 
and decrease in eGFR.   Also, the mean eGFR was found 
to be higher in subjects with no added risk compared to 
those with risk(s).  The above findings may be explained 
by the multi-hit hypothesis which states that multi-factors 
interact to overcome renal reserve and provoke progres-
sive nephron loss33. The magnitude of  the risk factors in 
newly diagnosed hypertensives therefore plays an import-
ant role in the subsequent reduction in renal reserve.
Conclusion
The study reports a high prevalence of  modifiable renal 
risk factors. These include analgesic abuse, herbal con-
coction and obesity amongst the newly diagnosed hyper-
tensives. Markers suggestive of  early impairment of  kid-
ney function as evident by microalbuminuria and reduced 
GFR were also present in a sizeable number of  patients 
and they stand a higher risk of  faster disease progression 
and of  having cardiovascular complications. This finding 
underscores the need to improve the awareness of  hy-
pertension in the population since this will lead to early 
detection.
Analgesic abuse and undefined herbal remedy usage 
should be discouraged. In conclusion, methods that 
could be used to stem down the risk factors especially in 
developing countries and indeed globally is through con-
tinuous promotion and advocacy of  healthy behaviours 
and habits via education and awareness.  
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